As the majority of Americans wait for their turn to get their Covid-19 vaccine, questions abound over what justifies one group to take priority over another. We discuss the ethical questions that arise in how vaccines are allocated and developed—and what these questions say about the moral values of our society.
Jessica Miller, clinical ethicist; professor of philosophy, University of Maine
Dr. James Jarvis, physician leader for incident command, Northern Light Health
Bjørn Hofmann, professor, Norwegian University of Science and Technology; specializes in philosophy of medicine
Erika Ziller, chair of public health, University of Southern Maine; specializes in rural health
Cliff Guthrie, faculty, Husson University; teaches and writes in the field of ethics, philosophy and religion
- As Maine CDC Focuses On High-Volume Vaccination Sites, Independent Physicians Question Access Equity
- Is It Ever OK To Jump Ahead In The Vaccine Line?
- The Vaccine Had to Be Used. He Used It. He Was Fired.
- Physicians Face Potential Peril With Leftover Vaccine Doses
- China approves Sinovac Biotech COVID-19 vaccine for general public use
- Oxford-AstraZeneca begins a vaccine trial for children. It’s the youngest group yet to be tested.
- Some Europeans get choosy about which vaccines they want